An anastomosis device (12) for advantageously bridging an artery and a vein. The anastomosis device includes a tubular graft (15) with first and second ends (47 and 48) and a longitudinal passageway extending longitudinally through the graft. The device further includes a first stent (10) disposed about the first end of the tubular graft and a second stent (10) disposed about the second end of the tubular graft. Each of the first and second stents has a plurality of hooks or barbs (11) pointed or releasable to the point toward the other end of the graft.
|
1. An anastomosis device comprising:
a tubular graft having a first end, a second end, and a longitudinal passageway from the first end to the second end;
a spring-loaded stent device attached to the tubular graft and comprising a first stent, a second stent, and one or more springs connected to the first and second stents;
where the springs bias the first stent towards the first end of the graft and the second stent towards the second end of the graft.
2. The anastomosis device of
3. The anastomosis device of
|
This application claims priority of provisional application Ser. No. 60/469,708, filed May 12, 2003.
The present invention relates to the field of medical devices and, in particular, an anastomosis device and method of use therefore.
Current devices and techniques exist which allow for open surgical attachment of an artery to a vein for vascular access or replacement of diseased vessels. This includes sewing in a graft between the internal mammary artery and a coronary vessel, the radial artery and cephalic vein, the brachial artery and cephalic vein, the brachial artery and basilica vein, the ulnar artery and basilica vein, the brachial artery to branches of the antecubital vein, and a saphenous vein loop fistula. To our knowledge, no known non-invasive methods or devices exist that employ non-invasive catheter delivery of an anastomosis device for access between these areas. Prior to using synthetic grafts, the radiologist or nephrologist's first choice is a naturally occurring vessel to act as an AV fistula for vascular access. Only after determining their inadequacy is a synthetic vessel or exogenous vessel (e.g., animal derived small intestine submucosa (SIS)) used.
The present invention is directed to an illustrative minimally invasive anastomosis device for advantageously bridging an artery and a vein. The device is loaded into a sheath or introducer system and pushed out over a wire to the desired location following the commonly used Seldinger technique, but with ultrasound guidance. This is done on both the artery and the vein. The system is preferably placed in the sagittal plane at an angle between 0 and 40 degrees, but preferably between 25 and 40 degrees. In the transverse plane, the system is placed between 0 and 45 degrees, but preferably between 30 and 45 degrees. Many of the connection segments between the graft and the vessel are thought to be unique and should be considered as such for the use of this device without catheters as in open surgical procedures.
The anastomosis device illustratively comprises a tubular graft with first and second ends and a longitudinal passageway extending therethrough. The device further comprises a first stent disposed about the first end of the tubular graft and a second stent disposed about the second end of the tubular graft. In addition, the first stent has hooks or barbs pointed or releasable to point toward the second end of the graft. Similarly, the second stent has at least hooks or barbs pointed or releasable to point toward the first end of the graft. The first and second stents are preferably self-expanding stents such as Z-stents. Alternatively, the stents can be balloon-expandable stents. These stents are resilient stents and comprise preferably nitinol or stainless steel.
The device further comprises an additional stent disposed at least approximately midway along the tubular graft. In addition, the device can comprise a plurality of these additional stents disposed along the graft.
The graft of the present invention comprises a biocompatible material including, for example, an extracellular collagen matrix material, a small intestine submucosa material, a synthetic material or other polymer graft material. The anastomosis device can further comprise an other tubular graft of which the first and second stents are disposed coaxially between the tubular grafts. A slidable collar can also be disposed around an end of the graft to further stabilize the graft within a blood vessel. In addition, the device can further include a surface modification or a coating inhibiting intimal hyperplasia or an exterior coating of a substance that induces homeostasis and includes at least one of fibrin, a fibrin-like substance, and thrombin.
Additionally, the device can include flares at one or more of the ends of the graft.
The graft, preferably made of small intestine submucosa, but not limited to commonly used synthetic graft materials, is the conduit that bridges the artery and the vein. At each end of the graft are stents 10 that are preferably made from nitinol and cold formed or heat set at greater than 400 F. The stents are anchored to the inside of the graft wall and provide a retention force when inserted into the blood vessel. The SIS material is preferably vacuum pressed around the stents, rehydrated, and then lyophilized before being placed in the introducer system to provide for optimal compliance. The SIS material must have enough layers, preferably three or more, in the graft to accommodate arterial blood pressure. The layers of SIS material may be adhered together with Fibrin glue. The SIS material may be sewn into a tubular form from a sheet as depicted in
The device of the present invention at each end of the graft may also include thrombin, or preferably fibrin or a fibrin-like substance that is applied to the exterior surface of the graft to assist with homeostasis. Fibrin is a naturally occurring substance that, when in contact with blood, causes a platelet plug to form and controls bleeding. Eyelets may also be placed at each bend of the stent or eyelets only at the connection points of the base stent and the top stent to help reduce stress at the bends. Adhesive bonding of the graft around the outside of the base stent may be used by folding the graft from the outside to the inside, gluing, then cutting off any excess.
Bates, Brian L., Paul, Jr., Ram H., Amarant, Paul D., Fette, Clay D.
Patent | Priority | Assignee | Title |
10034739, | Jun 18 2012 | Board of Regents of the University of Nebraska | Stent to assist in arteriovenous fistula formation |
10433847, | Dec 17 2013 | Board of Regents of the University of Nebraska | Platform device and method of use to assist in anastomosis formation |
10456239, | Jun 15 2011 | PHRAXIS INC | Anastomotic connector and system for delivery |
10772718, | Jun 18 2012 | Board of Regents of the University of Nebraska | Stent to assist in arteriovenous fistula formation |
10786346, | Jun 15 2012 | PHRAXIS INC. | Arterial anchor devices forming an anastomotic connector |
10835366, | Aug 16 2012 | PHRAXIS, INC | Arterial and venous anchor devices forming an anastomotic connector and system for delivery |
11020215, | Jun 15 2012 | PHRAXIS, INC. | Venous anchor devices forming an anastomotic connector |
11160555, | Dec 17 2013 | Board of Regents of the University of Nebraska | Platform device and method of use to assist in anastomosis formation |
11701216, | Jun 18 2012 | of Nebraska | Stent to assist in arteriovenous fistula formation |
11751876, | May 07 2019 | EasyfloMicro Inc. | Apparatuses for anastomosis of tubular vessels and related methods |
11938246, | Dec 24 2014 | FETTECH, LLC | Tissue-based compositions and methods of use thereof |
12109347, | Jun 19 2017 | The Regents of the University of California | Device and method for atraumatic and percutaneous formation of an arteriovenous fistula |
8197499, | Jun 21 2006 | The Board of Trustees of the Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
8216259, | Jun 21 2006 | The Board of Trustees of the Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
8608760, | Jun 21 2006 | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE | Compositions and methods for joining non-conjoined lumens |
8657866, | Dec 22 2010 | Cook Medical Technologies LLC | Emergency vascular repair prosthesis deployment system |
9011514, | Aug 22 2011 | Cook Medical Technologies LLC | Emergency vessel repair prosthesis deployment system |
9055946, | Nov 26 2008 | PHRAXIS INC.; PHRAXIS INC | Anastomotic connector |
9238090, | Dec 24 2014 | FETTECH, LLC | Tissue-based compositions |
9308311, | Jun 15 2011 | PHRAXIS, INC. | Arterial venous spool anchor |
9314358, | Dec 22 2010 | Cook Medical Technologies LLC | Emergency vascular repair prosthesis deployment system |
9549834, | Aug 22 2011 | Cook Medical Technologies LLC | Emergency vessel repair prosthesis deployment system |
9597443, | Jun 15 2011 | PHRAXIS, INC. | Anastomotic connector |
9675487, | Nov 17 2010 | Cook Medical Technologies LLC | Prosthesis deployment system for vascular repair |
Patent | Priority | Assignee | Title |
5749880, | Mar 10 1995 | Bard Peripheral Vascular, Inc | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
5755778, | Oct 16 1996 | W L GORE & ASSOCIATES, INC | Anastomosis device |
6440163, | Nov 06 1998 | St. Jude Medical ATG, Inc. | Medical anastomosis apparatus |
6451048, | Oct 09 1997 | ST JUDE MEDICAL ATG, INC | Wire connector structures for tubular grafts |
6485513, | Oct 08 1999 | Motorola Mobility LLC | Percutaneous stent graft and method for vascular bypass |
6638312, | Aug 04 2000 | Depuy Synthes Products, LLC | Reinforced small intestinal submucosa (SIS) |
6695833, | Sep 27 2000 | Endologix LLC | Vascular stent-graft apparatus and forming method |
6699263, | Apr 05 2002 | Cook Medical Technologies LLC | Sliding suture anchor |
6746480, | Feb 28 1996 | Bard Peripheral Vascular, Inc | Flanged graft for end-to-side anastomosis |
6818016, | Jun 27 1997 | MICHIGAN, THE REGENTS OF THE UNIVERSITY OF | Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo |
6908624, | Dec 23 1999 | Advanced Cardiovascular Systems, INC | Coating for implantable devices and a method of forming the same |
7175652, | Aug 20 2002 | Cook Medical Technologies LLC | Stent graft with improved proximal end |
20050049675, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
May 12 2004 | Cook Incorporated | (assignment on the face of the patent) | / | |||
May 12 2004 | Cook Biotech Incorporated | (assignment on the face of the patent) | / | |||
Aug 20 2007 | AMARANT, PAUL D | Cook Biotech Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019751 | /0455 | |
Aug 20 2007 | PAUL, RAM H JR | Cook Biotech Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019751 | /0455 | |
Aug 20 2007 | FETTE, CLAY D | Cook Biotech Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019751 | /0455 | |
Aug 20 2007 | BATES, BRIAN L | Cook Biotech Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019751 | /0455 | |
Aug 20 2007 | AMARANT, PAUL D | Cook Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019751 | /0455 | |
Aug 20 2007 | PAUL, RAM H JR | Cook Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019751 | /0455 | |
Aug 20 2007 | FETTE, CLAY D | Cook Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019751 | /0455 | |
Aug 20 2007 | BATES, BRIAN L | Cook Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019751 | /0455 | |
Mar 15 2011 | Cook Incorporated | Cook Medical Technologies LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 026287 | /0923 | |
Mar 15 2011 | Vance Products Incorporated | Cook Medical Technologies LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 026287 | /0923 | |
Mar 16 2011 | Sabin Corporation | Cook Medical Technologies LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 026287 | /0923 | |
Mar 16 2011 | Cook Vascular Incorporated | Cook Medical Technologies LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 026287 | /0923 | |
Mar 22 2011 | Wilson-Cook Medical Incorporated | Cook Medical Technologies LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 026287 | /0923 | |
Feb 01 2024 | Cook Biotech Incorporated | Cook Medical Technologies LLC | PATENT ASSIGNMENT AGREEMENT | 066436 | /0137 | |
Feb 27 2024 | Cook Medical Technologies LLC | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 066700 | /0277 |
Date | Maintenance Fee Events |
Sep 25 2013 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Sep 14 2017 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Sep 09 2021 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Apr 06 2013 | 4 years fee payment window open |
Oct 06 2013 | 6 months grace period start (w surcharge) |
Apr 06 2014 | patent expiry (for year 4) |
Apr 06 2016 | 2 years to revive unintentionally abandoned end. (for year 4) |
Apr 06 2017 | 8 years fee payment window open |
Oct 06 2017 | 6 months grace period start (w surcharge) |
Apr 06 2018 | patent expiry (for year 8) |
Apr 06 2020 | 2 years to revive unintentionally abandoned end. (for year 8) |
Apr 06 2021 | 12 years fee payment window open |
Oct 06 2021 | 6 months grace period start (w surcharge) |
Apr 06 2022 | patent expiry (for year 12) |
Apr 06 2024 | 2 years to revive unintentionally abandoned end. (for year 12) |